Recombinant shingles vaccination and the risk of cardiovascular events
Nature Medicine, Published online: 26 August 2026; doi:10.1038/s41591-026-04606-0 A natural experiment comparing recipients of the live attenuated versus recombinant herpes zoster vaccines found that the recombinant vaccine was associated with a lower incidence of cardiovascular events across 7 years of follow-up.
We haven't written up this one. Nature Medicine has the full story — the link below goes straight to it.